Recent News

• 02.13.2025 - Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
• 02.12.2025 - Applied DNA to Report First Quarter Fiscal 2025 Financial Results
• 02.11.2025 - APDN Reminds Shareholders to Vote Ahead of Special Meeting on February 14
• 02.11.2025 - APDN Reminds Shareholders to Vote Ahead of Special Meeting on February 14
• 01.10.2025 - Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates
• 01.08.2025 - Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
• 01.08.2025 - Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter
• 12.18.2024 - ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-cell Therapy Produced from LineaDNA

Recent Filings

• 02.13.2025 - 8-K Current report
• 02.13.2025 - EX-99.1 EX-99.1
• 02.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.11.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 01.30.2025 - 8-K Current report
• 01.23.2025 - 8-K Current report
• 01.17.2025 - EFFECT Notice of Effectiveness
• 01.17.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 01.13.2025 - 8-K Current report
• 01.13.2025 - EX-99.1 EX-99.1